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those that cause emerging and re-emerging infectious diseases. Along
with the ongoing COVID-19 pandemic, highly pathogenic avian influenza
(HPAI) viruses of the H5 subtype are attacking silently as a re-emerging dis-
ease, thus seriously impairing poultry and human health. Recently, there have
been outbreaks of the H5N8 subtype of HPAI virus in many regions around
the world. According to data available through the Global Animal Disease In-
formation System (http://empres-i.fao.org/) of the Food and Agriculture Or-
ganization of the United Nations, a total of 412 HPAI H5N8 outbreaks were
reported worldwide from August 31 to December 1, 2020, with 353,851 ani-
mals confirmed to be infected in 26 countries around theworld. Only sporadic
cases of this strain were found during the same period in the previous year.
The HPAI H5N8 virus was first isolated in 2010. It belongs to the clade
2.3.4.4 ofHPAIH5N1 (Gs/GD lineage), which undergoes reassortment, swap-
ping its neuraminidase and other segments. HPAI H5N8 emerged and thenA
B
C
llspread intercontinentally. Multiple HPAI H5N8 outbreaks have occurred
worldwide, with large epidemics in 2014/20151 and 2016/2017.2 At the
beginning of 2020, H5N8was again detected in Europe, and two novel strains
of HPAI H5N8 were isolated in Germany. In October, a strain with high nucle-
otide homology to the German samples was isolated from field samples in
South Korea, indicating that this strain had been transmitted intercontinen-
tally. At present, it appears that these HPAI H5N8 strains have undergone
further reassortments, although identification and analysis of the 2020
strains are still ongoing.
Although noHPAI H5N8 human infections have been reported so far, it still
needs to be taken seriously (Figure 1). Strains of the clade 2.3.4.4 have been
found to infect cats and pigs, and clade 2.3.4.4H5N6has caused infections in
humans. Under laboratory conditions, some strains of the H5N8 subtype can
seriously infect minks and transmit via direct contact. Whole-genome ana-
lyses of HPAI H5N8 have shown the molecular characteristics, includingFigure 1. Overview of the Emergence, Spread, and
Outbreak of Highly Pathogenic Avian Influenza (HPAI) Vi-
ruses of H5N8 (A) Chart of H5N8 HPAI cases in various
countries from January 1 to December 1, 2020. Different
colors indicate case range.
(B) Major events in the history of H5N8 HPAI. Several
neuraminidase enzymes, including N8, were obtained by
recombination of the H5N1 HPAI with other low-pathogenic
avian influenza (LPAI) viruses.
(C) Transmission chain of H5 subtype of influenza A virus.
Wildfowl may carry HPAI and LPAI viruses, including H5Ny,
HxN1, and HxN8, asymptomatically and interact with
poultry. HPAI H5N1 in poultry may infect humans, but the
possibility of human-to-human transmission is not clear.
There is currently no evidence of HPAI H5N8 infection in
humans.








onPB2-613I and PB2-702R, related to genes found in strains infecting human
beings after the 2014 outbreak of HPAI H5N8, indicating that HPAI H5N8
has the potential to infect human beings to a certain extent.
However, we are not helpless against virus outbreaks, as scientists have
taken great efforts in virus prevention and control. For virus detection, a
method for the detection of HPAI H5N8 using the TaqMan minor groove
binder and real-time reverse transcriptase-polymerase chain reaction has
been reported, with its sensitivity reaching 10 copies per reaction.3 In vaccine
research and development, several key amino acid mutation sites have been
reported to lead to an antigenic drift in the hemagglutinin antigenic determi-
nant B of clade 2.3.4.4. In addition, titers of the strains of clade 2.3.4.4 in chick
embryos have been greatly improved through specific gene modification,
while the modified virus strain does not infect mammals.4 These studies
lay a solid foundation for the research and development of highly effective
HPAI H5N8 vaccines.
Nevertheless, vaccines alone are not a long-term solution for the preven-
tion and control of influenza A virus outbreaks. As we know, it is not practical
to vaccinate all the wild birds, which are the ultimate problem in the spread of
H5N8 to Europe. Ongoing monitoring has shown that whether the develop-
ment and application of a vaccine may create significant selective pressure
on the evolution of the influenza A virus is also a concern.5 Furthermore,
various public health factors, such as rampant live poultry trading in Asia,
imperfect vaccination and elimination programs, and an intercontinental
HPAI monitoring network that needs improvement, are considered to be
strongly associated with the prevalence of HPAI.
Finally, the explosive population growth in the 21st century has led to
increased demands on the global breeding industry, and the challenges of
HPAI compel us to face this global difficulty together. To maintain the prev-2 The Innovation 2, 100084, February 28, 2021alence of HPAI in domestic bird populations, health authorities at all levels of
government and international organizations need to coordinate and coop-
erate to identify ways to minimize the threat posed by these viruses.
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